SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Psykiatri) ;conttype:(scientificother)"

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Psykiatri) > Övrigt vetenskapligt/konstnärligt

  • Resultat 1-10 av 1259
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Trägårdh, Karin, et al. (författare)
  • Risk Profiles of Female Perpetrators of Severe Violence
  • 2019
  • Ingår i: 13th Nordic Symposium on Forensic Psychiatry. August 20-22, Gothenburg, Sweden.
  • Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
    • Female offenders without a severe mental disorder show more criminogenic factors than those with. Both groups are characterized by mental health problems. We need to further characterize female offenders. Background Offenders of lethal/severe violence are in a majority of cases male, about 90% (Falk et al., 2014), and research has to a considerable extent focused on male violent offenders. Although less is known about female violent offenders than male offenders, previous research has indicated significant differences between male and female offenders of lethal/severe violence (Trägårdh et al., 2016; Yourstone et al., 2008). Since a majority of female perpetrators of lethal violence undergo a forensic psychiatric investigation (RPU/FPI), these documents contains important information about this group. Purpose The aim of this ongoing study is to characterize female perpetrators of severe violent crimes, and to compare female perpetrators sentenced to forensic psychiatric compulsory care with those sentenced to correctional treatment. Method This is an exploratory and descriptive study with a cross-sectional design. All forensic evaluations (FPI) made in Sweden between 2000-2014 (from The National Board of Forensic Medicine/RMV), and the subsequent court verdicts, in cases where women had used lethal/severe violence (n≈180) where used as the basis for data collection in this study. The present preliminary analyses (2-tests and ANOVA) contains approx. 26% (n=47) of the total group. Group differences were investigated regarding: Mental health (FPI) Risk factors (HCR-20 and PCL-R) Victim relation (FPI) Criminal behavior (FPI) Results Female offenders with and without a Severe mental disorder (SMD) seems to differ in some respects. For female offenders with a SMD, the crime was more likely to have been conducted in a less criminal context (see Table). For female offenders without a SMD, the following characteristics were more frequently present: Victim gender – male Substance abuse + Under the influence of substance (offender and victim) Previous violence between victim and offender Previous registered criminality Also, several common features between the SMD and non-SMD group of female offenders were found. The majority of all female offenders had: Previous psychiatric contact and diagnoses Previously attempted suicide No previously registered criminality Conclusions Preliminary results of the female perpetrators who had underwent a FPI seems to identify both substantial differences and similarities between those with versus without a SMD, where those without show more criminogenic factors. Both groups were also characterized by a high amount of mental illness. Also, these results supports previous research that female and male offenders of severe violence differ in important ways. Since a majority of female perpetrators of lethal violence undergo a forensic psychiatric investigation, these results should be generalizable to this group as a whole in Sweden. Based on these results, a great need to further characterize female offenders of severe/lethal violence remain.
  •  
2.
  • Falk Erhag, Hanna, et al. (författare)
  • A Multidisciplinary Approach to Capability in Age and Ageing
  • 2022
  • Bok (övrigt vetenskapligt/konstnärligt)abstract
    • This open access book provides insight on how to interpret capability in ageing – one’s individual ability to perform actions in order to reach goals one has reason to value – from a multidisciplinary approach. With for the first time in history there being more people in the world aged 60 years and over than there are children below the age of 5, the book describes this demographic trends as well as the large global challenges and important societal implications this will have such as a worldwide increase in the number of persons affected with dementia, and in the ratio of retired persons to those still in the labor market. Through contributions from many different research areas, it discussed how capability depends on interactions between the individual (e.g. health, genetics, personality, intellectual capacity), environment (e.g. family, friends, home, work place), and society (e.g. political decisions, ageism, historical period). The final chapter by the editors summarizes the differences and similarities in these contributions. As such this book provides an interesting read for students, teachers and researchers at different levels and from different fields interested in capability and multidisciplinary research.
  •  
3.
  • Olsson, Lars-Eric, 1951, et al. (författare)
  • Höftfraktur
  • 2009
  • Ingår i: Prehospital akutsjukvård Redaktörer Leif Svensson Björn-Ove Suserud. - Stockholm : Liber. - 9789147084487 ; , s. 428-434
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
4.
  • Söderquist, Fanny (författare)
  • Melatonin in the gastrointestinal tract
  • 2019
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • Melatonin is recognised as the pineal hormone regulating sleep and circadian rhythm. It has also been identified in peripheral tissues (mainly in animals) and thought to display a variety of actions, including anti-inflammatory properties, regulation of gastrointestinal (GI) functions, glucose homeostasis and beneficial effects in different tumour types. Patients with irritable bowel disorder commonly exhibit psychiatric co-morbidity and disturbances of the gut-brain axis have been proposed to play a role in these disorders. The focus of this thesis was to study melatonin and melatonin receptors in the normal human GI tract, the pancreas and small intestinal neuroendocrine tumours. The thesis also explores the complex relationship between GI symptoms and underlying psychiatric traits in the context of elevated levels of peripheral melatonin during waking hours.In paper I-II, tissue samples from the normal human GI tract and pancreas and tumour tissue from small intestinal neuroendocrine tumours were analysed for expression of melatonin and melatonin receptors using immunohistochemistry. For tumour patients, melatonin was also analysed in plasma and set in relation to symptoms and outcome. In paper III-IV, a cohort of young adults (18-25 years) seeking psychiatric care was examined for GI symptoms, melatonin levels in saliva, depressive symptoms and anxiety traits. Psychiatric assessments were performed using structured or semi structured interviews. Depressive symptoms were measured using the self-rating version of the Montgomery-Åsberg Depression Rating Scale; GI symptoms were measured using the Gastrointestinal Symptoms Rating Scale for Irritable Bowel Syndrome; and personality traits were evaluated using the Swedish Universities Scales of Personality.Melatonin and melatonin receptors were widely expressed in the normal human gut and pancreas (paper I) but even in small intestinal neuroendocrine tumours known to produce serotonin (paper II). The intensity of the melatonin immunoreactivity in tumour tissue was found to correlate with lower proliferation index. After treatment, plasma levels of melatonin were reduced in tumour patients. Young adult patients seeking psychiatric care reported more GI symptoms than healthy controls, regardless of the currently active psychotropic medication. The level of GI symptoms was associated with severity of depressive symptoms and trait anxiety (paper III). Higher postprandial levels of melatonin were associated with the GI symptoms of bloating and pain (paper IV).In summary, these findings demonstrate the widespread presence of melatonin in the human gut and confirm a link between melatonin, psychiatric health and GI symptoms.
  •  
5.
  • Klaric, Lucija, et al. (författare)
  • Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19.
  • 2021
  • Ingår i: medRxiv : the preprint server for health sciences. - : Cold Spring Harbor Laboratory. ; , s. 1-28
  • Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
    • Severe COVID-19 is characterised by immunopathology and epithelial injury. Proteomic studies have identified circulating proteins that are biomarkers of severe COVID-19, but cannot distinguish correlation from causation. To address this, we performed Mendelian randomisation (MR) to identify proteins that mediate severe COVID-19. Using protein quantitative trait loci (pQTL) data from the SCALLOP consortium, involving meta-analysis of up to 26,494 individuals, and COVID-19 genome-wide association data from the Host Genetics Initiative, we performed MR for 157 COVID-19 severity protein biomarkers. We identified significant MR results for five proteins: FAS, TNFRSF10A, CCL2, EPHB4 and LGALS9. Further evaluation of these candidates using sensitivity analyses and colocalization testing provided strong evidence to implicate the apoptosis-associated cytokine receptor FAS as a causal mediator of severe COVID-19. This effect was specific to severe disease. Using RNA-seq data from 4,778 individuals, we demonstrate that the pQTL at the FAS locus results from genetically influenced alternate splicing causing skipping of exon 6. We show that the risk allele for very severe COVID-19 increases the proportion of transcripts lacking exon 6, and thereby increases soluble FAS. Soluble FAS acts as a decoy receptor for FAS-ligand, inhibiting apoptosis induced through membrane-bound FAS. In summary, we demonstrate a novel genetic mechanism that contributes to risk of severe of COVID-19, highlighting a pathway that may be a promising therapeutic target.
  •  
6.
  • Lindén, Thomas, 1962 (författare)
  • Demens efter stroke.
  • 2007
  • Ingår i: E-publikation Vårdalinstitutets hemsida "Tematiska rum" 2007.
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
7.
  • Lindén, Thomas, 1962, et al. (författare)
  • Plasticitet, kognition och rehabilitering
  • 2009
  • Ingår i: Peter-Eriksson-symposiet "Den Stressade Hjärnan", Göteborg, december 2009.
  • Konferensbidrag (övrigt vetenskapligt/konstnärligt)
  •  
8.
  • Pellas, Johnny (författare)
  • Assessment and psychological treatment of depression in older adults
  • 2023
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • Depression is one of the leading causes of disability in older adults worldwide. Many older adults with depression are undetected, and there is a need for brief, scalable psychological treatments for depression that can be delivered remotely.The aims of this thesis were 1) to investigate the diagnostic accuracy of two rating scales (PHQ-9 and GDS-15) for the detection of depression in older adults, and 2) to investigate the feasibility, preliminary efficacy and patients’ experiences of a telephone-based psychological intervention, Behavioral activation with mental imagery (BA-MI), for the treatment of depression in older adults in the context of the covid-19 pandemic. Study I showed that a cutoff of ≥6 on the GDS-15 and ≥5 on the PHQ-9 were optimal to identify major depressive disorder. When identifying both major depressive disorder and subthreshold depression, the optimal cutoff on the GDS-15 was ≥5. Study II was a randomized clinical pilot trial, CoviDep, with a treatment group receiving the BA-MI intervention, and a control group. The drop-out rate was low. Compared to the control group, the treatment group reported a decrease in depressive symptoms throughout the treatment, with a large effect-size at posttreatment. Study III was a long-term follow-up of participants in CoviDep that received the BA-MI intervention. The drop-out rate over time was low, and compared to baseline, decreases in depressive symptoms were observed with a medium effect-size at posttreatment that was maintained 1- and 3 months post-treatment but lower after 6 months. Study IV was a qualitative study. The BA-MI intervention in CoviDep was described as increasing activities and improving mood. Telephone-delivery reduced barriers due to pandemic restrictions but felt less personal and lacking non-verbal communication. Being recognized and talking to a therapist every week was healing, but the manualized mode of treatment seemed to impair the relationship.In sum, this thesis shows that both the GDS-15 and the PHQ-9 are useful tools for the detection of depression in older adults, and adds to the support for telephone-delivered BA for the treatment of depression and indicates that MI-interventions are feasible as an augmentation of BA in older adults.
  •  
9.
  • Schmidt, Hartmut, et al. (författare)
  • Patisiran ph 2 open-label extension study in Familial Amyloidotic Polyneuropathy
  • 2016
  • Ingår i: Journal of Neurology, Neurosurgery and Psychiatry. - : BMJ. - 0022-3050 .- 1468-330X. ; 87:12
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Background: Familial Amyloid Polyneuropathy (FAP) is a progressive disease caused by deposition of transthyretin (TTR). Patisiran is an investigational, small interfering RNA (siRNA) inhibiting TTR. This abstract highlights patisiran's long-term safety. Methods: Phase 2 OLE study to evaluate patisiran's safety. Patisiran's effect on serum TTR levels, impact on neuropathy impairment scores and QOL were assessed. Results: 27 patients with FAP enrolled; median age 64 years. Patisiran was generally well tolerated out to 23-months. Five patients experienced SAEs (unrelated) including one discontinuation (gastroesophageal cancer); patient subsequently died. Flushing (25.9%) and infusion-related reactions (18.5%) were mild in severity; no discontinuations resulted. Approximately 80% sustained mean serum TTR lowering resulted with a mean nadir of up to 93% between doses. Among the 20 evaluable patients, neuropathy impairment scores were stable through 18-months; mean change in mNIS+7 and NIS of 1.7 and 4.2 points, respectively. This compares favorably to 17–26 point mNIS+7/NIS increase estimated at 18-months from prior FAP studies. Stabilization of QOL measures and improvement of distal thigh sweat gland nerve fiber density observed. Conclusion: Data demonstrates that 18-months of patisiran administration was generally well tolerated, resulted in sustained mean serum TTR lowering, supporting the hypothesis that TTR knockdown potentially halts neuropathy progression.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 1259
Typ av publikation
tidskriftsartikel (358)
doktorsavhandling (300)
konferensbidrag (192)
bokkapitel (161)
annan publikation (95)
rapport (84)
visa fler...
bok (40)
samlingsverk (redaktörskap) (12)
licentiatavhandling (7)
recension (6)
forskningsöversikt (2)
proceedings (redaktörskap) (1)
patent (1)
visa färre...
Typ av innehåll
Författare/redaktör
Gillberg, Christophe ... (44)
Edvardsson, Bo, 1944 ... (34)
Larsson, Henrik, 197 ... (33)
Malmgren, Helge, 194 ... (30)
Garcia, Danilo, 1973 (23)
Nilsson, Thomas, 195 ... (23)
visa fler...
Blennow, Kaj, 1958 (22)
Munthe, Christian, 1 ... (22)
Zetterberg, Henrik, ... (21)
Andiné, Peter (21)
Lichtenstein, Paul (19)
Landén, Mikael, 1966 (18)
Fernell, Elisabeth, ... (18)
Werneke, Ursula (15)
Holmes, Emily A. (14)
Nylander, Lena (14)
Furmark, Tomas (14)
Skoog, Ingmar, 1954 (13)
Anckarsäter, Henrik, ... (13)
Wentz, Elisabet, 196 ... (12)
Andersson, Gerhard (12)
Hofvander, Björn (12)
Kuja-Halkola, Ralf (12)
Ekselius, Lisa (11)
Gerdner, Arne (11)
Jokinen, Jussi (11)
Svedin, Carl Göran (11)
Priebe, Gisela (10)
Bengtsson Tops, Anit ... (10)
Ott, Michael (9)
Lundström, Sebastian (9)
Bejerot, Susanne, 19 ... (9)
Sarkohi, Ali, 1961- (9)
Wallinius, Märta, 19 ... (9)
Fredrikson, Mats (8)
Adolfsson, Rolf (8)
Portelius, Erik, 197 ... (8)
Kjellin, Lars (8)
Cloninger, Kevin M. (8)
Cervenka, Simon (8)
Andersson, Gerhard, ... (8)
Cloninger, C. Robert (8)
Salander Renberg, El ... (8)
Cantor-Graae, Elizab ... (7)
Ramklint, Mia, Docen ... (7)
Nilsson, Karin (7)
Radovic, Susanna, 19 ... (7)
Sandlund, Mikael (7)
Mattsson, Niklas, 19 ... (7)
Humble, Mats B., 195 ... (7)
visa färre...
Lärosäte
Göteborgs universitet (391)
Uppsala universitet (200)
Umeå universitet (170)
Lunds universitet (164)
Örebro universitet (148)
Karolinska Institutet (90)
visa fler...
Linköpings universitet (80)
Stockholms universitet (29)
Jönköping University (28)
Mittuniversitetet (22)
Linnéuniversitetet (17)
Karlstads universitet (14)
Högskolan Kristianstad (10)
Malmö universitet (9)
Marie Cederschiöld högskola (8)
Röda Korsets Högskola (8)
Kungliga Tekniska Högskolan (7)
Gymnastik- och idrottshögskolan (7)
Sveriges Lantbruksuniversitet (6)
Högskolan i Gävle (5)
Högskolan Väst (5)
Högskolan Dalarna (4)
Södertörns högskola (3)
Chalmers tekniska högskola (3)
Högskolan i Borås (3)
Stockholms konstnärliga högskola (3)
Högskolan i Halmstad (2)
Mälardalens universitet (2)
Högskolan i Skövde (2)
Luleå tekniska universitet (1)
Handelshögskolan i Stockholm (1)
VTI - Statens väg- och transportforskningsinstitut (1)
visa färre...
Språk
Engelska (930)
Svenska (326)
Norska (1)
Spanska (1)
Bosniska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (1259)
Samhällsvetenskap (246)
Humaniora (86)
Naturvetenskap (6)
Teknik (1)
Lantbruksvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy